1. Anlotinib plus oral fluoropyrimidine S-1 in refractory or relapsed small-cell lung cancer (SALTER TRIAL): a multicenter, single-arm, phase II trial
   Wei Wang et al, 2024, BMC Cancer CrossRef
2. Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer
   Xinhang Xia et al, 2022, Analytical Cellular Pathology CrossRef